Mariko F. Taga, PhD

Academic Appointments

  • Instructor in Neurology Sciences (in Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain) at CUMC
Mariko F. Taga, PhD

Mariko Taga, PhD is an Instructor of Neurological Sciences (in Neurology, the Taub Institute and the Center for Translational and Computational Neuroimmunology), in the Division of Neuroimmunology. Dr. Taga received her PhD in neuroscience from the University of Southampton, UK in 2015. During her graduate studies, she examined the potential link between metabolic disorders and the chronic inflammation present in Alzheimer's disease, as a potential key contributor to dementia. She joined the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital to investigate the implications of genetic variants in Alzheimer's disease, specifically genes related to the innate immune system and she continued her research fellowship at the Taub Institute.

Dr. Taga’s current research focuses on the influence of peripheral inflammation on different glia cells in neurodegenerative disorders.

Departmental Appointments

  • Department of Neurology
    Division of Neuroimmunology

NIH Grants

  • MULTI-OMIC NETWORK-DIRECTED PROTEOFORM DISCOVERY, DISSECTION AND FUNCTIONAL VALIDATION TO PRIORITIZE NOVEL AD THERAPEUTIC TARGETS (Federal Gov)

    Sep 30 2018 - Aug 31 2023

    IDENTIFYING THE MOLECULAR SYSTEMS, NETWORKS, AND KEY MOLECULES THAT UNDERLIE COGNITIVE RESILIENCE (Federal Gov)

    Sep 15 2017 - May 31 2022

    ALZHEIMER S DISEASE RESEARCH CENTER - OVERALL (Federal Gov)

    Jun 15 2015 - May 31 2021

    DISSEMINATING KNOWLEDGE TO PREVENT NEURODEGENERATIVE DISEASE (Private)

    Nov 1 2019 - Oct 31 2020

    ALZHEIMER S DISEASE RESEARCH CENTER - OVERALL (Federal Gov)

    Jun 15 2015 - May 31 2020

    INFLUENCE OF GENOTYPE ON MICROGLIA PHENOTYPE AND FUNCTION IN PD (Federal Gov)

    Jul 1 2017 - Jun 30 2019

    INFLUENCE OF GENOTYPE ON MICROGLIA PHENOTYPE AND FUNCTION IN PD (Federal Gov)

    Jul 1 2017 - Jun 30 2019

    PATHWAY DISCOVERY, VALIDATION AND COMPOUND IDENTIFICATION FOR ALZHEIMER S DISEASE (Federal Gov)

    Sep 20 2013 - Aug 31 2018